Open Beta
MetriLume

US marketsALEC

SEC-sourced researchBeta

ALEC

Alector, Inc.

Company comparison ↗

Data passport

CIK
0001653087
Exchange
Nasdaq
Business activity
Biological Products, (No Diagnostic Substances) · SIC 2836
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 100,558,000.0000 USD; December 2025: 21,045,000.0000 USD100.6M USD0 USD0December 2024December 2025
ALEC · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024100,558,000.0000Feb 25, 2026
December 202521,045,000.0000Feb 25, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202521,045,000.0000-142,929,000.0000-184,031,000.0000293,237,000.0000262,588,000.0000Feb 25, 2026
December 2024100,558,000.0000-119,049,000.0000-229,905,000.0000468,303,000.0000341,503,000.0000Feb 25, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

22/100
Profitability0
Growth0
Balance sheet10
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$21.05MJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$100.56MJan 1, 2024 – Dec 31, 2024Feb 25, 202610-K
Net incomeNetIncomeLoss-$142.93MJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$184.03MJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Total assetsAssets$293.24MDec 31, 2025Feb 25, 202610-K
Total liabilitiesLiabilities$262.59MDec 31, 2025Feb 25, 202610-K

New filings

Explore methodology ↗